EMMESSA Q1 FY27 results at a glance
EMMESSAR BIOTECH & NUTRITION L Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹0.06 cr |
|---|
| Revenue YoY | -36.1% |
|---|
| Operating profit | -₹0.38 cr |
|---|
| Operating margin | -633.2% |
|---|
| Net profit | ₹0.13 cr |
|---|
| Net profit YoY | -23.2% |
|---|
| Net profit QoQ | +284.5% |
|---|
| Net margin | 221.8% |
|---|
| Basic EPS | ₹0.26 |
|---|
| TTM revenue | ₹0.34 cr |
|---|
| TTM net profit | ₹0.4 cr |
|---|
| TTM net margin | 117.5% |
|---|
EMMESSA Q1 FY27 results: what the numbers say
EMMESSAR BIOTECH & NUTRITION L (EMMESSA) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹0.06 cr and a net profit of ₹0.13 cr, translating into earnings per share of ₹0.26.
Compared with the same quarter a year earlier, revenue declined strongly by -36.1% and net profit declined strongly by -23.2%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at -₹0.38 cr, an operating margin of -633.2% versus -325.8% a year ago — a contraction of 307.5 percentage points.
EMMESSA quarter-wise results table
Revenue
₹0.06 cr
-36.1% YoY
Net profit
₹0.13 cr
-23.2% YoY
Operating profit
-₹0.38 cr
-24.2% YoY
EMMESSAR BIOTECH & NUTRITION L (EMMESSA) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹0.06 cr | -₹0.38 cr | ₹0.13 cr | -633.2% | 221.8% | ₹0.26 | -23.2% | +284.5% |
| Q4 FY262026-03-31 | ₹0.09 cr | -₹0.39 cr | ₹0.03 cr | -423.7% | 36.9% | ₹0.07 | — | -70.6% |
| Q3 FY262025-12-31 | ₹0.09 cr | -₹0.36 cr | ₹0.12 cr | -386.3% | 124.6% | ₹0.23 | — | +2.1% |
| Q2 FY262025-09-30 | ₹0.09 cr | -₹0.4 cr | ₹0.11 cr | -434.0% | 124.3% | ₹0.23 | — | -33.4% |
| Q1 FY262025-06-30 | ₹0.09 cr | -₹0.3 cr | ₹0.17 cr | -325.8% | 184.5% | ₹0.34 | — | — |
| TTM (last 4 quarters) | ₹0.34 cr | -₹1.53 cr | ₹0.4 cr | -453.0% | 117.5% | ₹0.79 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
EMMESSA quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
EMMESSAR BIOTECH & NUTRITION L quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹0.06 cr | ₹0.09 cr | ₹0.09 cr | ₹0.09 cr | ₹0.09 cr |
|---|
| Total expenses | ₹0.43 cr | ₹0.49 cr | ₹0.45 cr | ₹0.49 cr | ₹0.4 cr |
|---|
| Gross profit | ₹0.04 cr | ₹0.06 cr | ₹0.06 cr | ₹0.07 cr | ₹0.06 cr |
|---|
| Operating profit (EBIT) | -₹0.38 cr | -₹0.39 cr | -₹0.36 cr | -₹0.4 cr | -₹0.3 cr |
|---|
| Operating margin | -633.2% | -423.7% | -386.3% | -434.0% | -325.8% |
|---|
| Interest cost | ₹0 cr | ₹0 cr | ₹0 cr | ₹0 cr | ₹0 cr |
|---|
| Profit before tax | ₹0.16 cr | ₹0.08 cr | ₹0.13 cr | ₹0.14 cr | ₹0.23 cr |
|---|
| Tax expense | ₹0.03 cr | ₹0.05 cr | ₹0.01 cr | ₹0.03 cr | ₹0.06 cr |
|---|
| Effective tax rate | 19.3% | 57.0% | 9.3% | 18.7% | 26.0% |
|---|
| Net profit (PAT) | ₹0.13 cr | ₹0.03 cr | ₹0.12 cr | ₹0.11 cr | ₹0.17 cr |
|---|
| Net profit margin | 221.8% | 36.9% | 124.6% | 124.3% | 184.5% |
|---|
| Basic EPS | ₹0.26 | ₹0.07 | ₹0.23 | ₹0.23 | ₹0.34 |
|---|
| Diluted EPS | ₹0.26 | ₹0.07 | ₹0.23 | ₹0.23 | ₹0.34 |
|---|
EMMESSA results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | -36.1% | — | — | — | — |
|---|
| Revenue QoQ | -36.1% | -0.6% | +1.9% | -1.2% | — |
|---|
| Operating profit YoY | -24.2% | — | — | — | — |
|---|
| Operating profit QoQ | +4.5% | -9.0% | +9.3% | -31.7% | — |
|---|
| Net profit YoY | -23.2% | — | — | — | — |
|---|
| Net profit QoQ | +284.5% | -70.6% | +2.1% | -33.4% | — |
|---|
| EPS YoY | -23.5% | — | — | — | — |
|---|
| EPS QoQ | +279.8% | -70.2% | 0.0% | -32.4% | — |
|---|
EMMESSA annual results history
Full-year performance for EMMESSAR BIOTECH & NUTRITION L, useful for reading each quarter in context.
EMMESSAR BIOTECH & NUTRITION L annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹0.37 cr | ₹0.61 cr | ₹0.56 cr | ₹1.02 cr |
|---|
| Total expenses | ₹1.82 cr | ₹1.66 cr | ₹1.73 cr | ₹1.78 cr |
|---|
| Gross profit | ₹0.28 cr | ₹0.43 cr | ₹0.36 cr | ₹0.62 cr |
|---|
| Operating profit (EBIT) | -₹1.45 cr | -₹1.05 cr | -₹1.18 cr | -₹0.76 cr |
|---|
| Operating margin | -391.7% | -171.6% | -211.9% | -74.9% |
|---|
| Interest cost | ₹0 cr | ₹0 cr | ₹0 cr | — |
|---|
| Profit before tax | ₹0.58 cr | ₹0.96 cr | ₹0.81 cr | ₹0.97 cr |
|---|
| Tax expense | ₹0.14 cr | ₹0.64 cr | ₹0.06 cr | ₹0.46 cr |
|---|
| Effective tax rate | 24.8% | 67.0% | 7.8% | 47.9% |
|---|
| Net profit (PAT) | ₹0.44 cr | ₹0.32 cr | ₹0.75 cr | ₹0.5 cr |
|---|
| Net profit margin | 117.5% | 51.7% | 135.0% | 49.4% |
|---|
| Basic EPS | ₹0.87 | ₹0.63 | ₹1.48 | ₹0.99 |
|---|
| Diluted EPS | ₹0.87 | ₹0.63 | ₹1.48 | ₹0.99 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹0.06 cr against ₹0.09 cr in Q1 FY26, and ₹0.09 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue declined -36.1%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹0.43 cr, or 733.2% of revenue, with operating profit declined -24.2% year on year.
Margins, tax and profitability
Net profit of ₹0.13 cr works out to a net margin of 221.8% compared with 184.5% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, EMMESSAR BIOTECH & NUTRITION L reported profit before tax of ₹0.16 cr, a tax charge of ₹0.03 cr (effective rate 19.3%), interest cost of ₹0 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹0.03 cr in Q4 FY26 to ₹0.13 cr in Q1 FY27, a change of +284.5%.
Trailing twelve months and annual context
Across the trailing four quarters EMMESSAR BIOTECH & NUTRITION L has generated revenue of ₹0.34 cr and net profit of ₹0.4 cr, a trailing net margin of 117.5%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹0.37 cr with net profit of ₹0.44 cr and EPS of ₹0.87, versus the prior year where revenue declined -39.3% and profit grew +37.8%.
What to watch in the next EMMESSA quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
EMMESSAR BIOTECH & NUTRITION L has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
EMMESSA results coverage
No results report published for EMMESSA yet — our desk covers each quarter within minutes of the filing.
EMMESSA quarterly results FAQs
What were EMMESSAR BIOTECH & NUTRITION L (EMMESSA) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), EMMESSAR BIOTECH & NUTRITION L reported revenue of ₹0.06 cr and net profit of ₹0.13 cr, a change of -23.2% year on year on -36.1% revenue growth. EPS stood at ₹0.26.
What is EMMESSA profit margin in Q1 FY27?
EMMESSAR BIOTECH & NUTRITION L posted a net profit margin of 221.8% and an operating margin of -633.2% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹0.34 cr and net profit ₹0.4 cr.
Did EMMESSA results beat the previous quarter?
EMMESSAR BIOTECH & NUTRITION L net profit changed +284.5% quarter on quarter, from ₹0.03 cr in Q4 FY26 to ₹0.13 cr in Q1 FY27.
When are EMMESSAR BIOTECH & NUTRITION L (EMMESSA) quarterly results?
EMMESSAR BIOTECH & NUTRITION L has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see EMMESSA latest quarterly results?
Results coverage for EMMESSA will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the EMMESSA stock page.
What is EMMESSAR BIOTECH & NUTRITION L annual revenue and profit?
For FY26, EMMESSAR BIOTECH & NUTRITION L reported full-year revenue of ₹0.37 cr and net profit of ₹0.44 cr, with EPS of ₹0.87.
How many quarterly results has EMMESSA declared recently?
Past results dates for EMMESSA will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
